» Articles » PMID: 33874991

Kawasaki Disease Recurrence in the COVID-19 Era: a Systematic Review of the Literature

Overview
Journal Ital J Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2021 Apr 20
PMID 33874991
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Kawasaki disease (KD) is a vasculitis of unknown origin of small and medium caliber blood vessels, especially involving coronary arteries and is the leading cause of acquired heart disease in childhood in developed countries. Although rarely, it can recur: most recurrences occur within 2 years of the initial episode. No data are available on incidence of recurrent KD in Europe and multiple recurrences are rarely seen. We reviewed the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection. We believe that in our case SARS Cov2 acted as a trigger capable to determine, in a genetically susceptible individual, a second recurrence of the disease. In the Covid-19 era we affirm the importance for Kawasaki disease to be tested for SARS Cov2 infection.

Citing Articles

Ocular manifestations of COVID-19 in pediatric patients.

Ichhpujani P, Singh R, Dhillon H, Kumar S Ther Adv Ophthalmol. 2023; 15:25158414221149916.

PMID: 36938488 PMC: 10015281. DOI: 10.1177/25158414221149916.


A global bibliometric analysis on Kawasaki disease research over the last 5 years (2017-2021).

Tan W, Jing L, Wang Y, Li W Front Public Health. 2023; 10:1075659.

PMID: 36703854 PMC: 9871775. DOI: 10.3389/fpubh.2022.1075659.


Clinical outcomes of COVID-19 infection in congenital heart disease: A single-center experience in Indonesia.

Siagian S, Oetama S, Pohan F, Mendel B, Lelya O, Sakti D Front Cardiovasc Med. 2022; 9:1022183.

PMID: 36386329 PMC: 9663915. DOI: 10.3389/fcvm.2022.1022183.


Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.

Maronese C, Zelin E, Avallone G, Moltrasio C, Romagnuolo M, Ribero S Front Med (Lausanne). 2022; 9:996288.

PMID: 36082274 PMC: 9445267. DOI: 10.3389/fmed.2022.996288.


The year 2021 in COVID-19 pandemic in children.

Bozzola E, Caffarelli C, Santamaria F, Corsello G Ital J Pediatr. 2022; 48(1):161.

PMID: 36064605 PMC: 9444079. DOI: 10.1186/s13052-022-01360-0.


References
1.
Pierre R, Sue-Ho R, WATSON D . Kawasaki syndrome in Jamaica. Pediatr Infect Dis J. 2000; 19(6):539-43. DOI: 10.1097/00006454-200006000-00010. View

2.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P . Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-1608. PMC: 7204765. DOI: 10.1016/S0140-6736(20)31094-1. View

3.
Lin K, Chang S, Yu C, Lin S, Liu S, Chao H . Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open. 2015; 5(4):e006703. PMC: 4401842. DOI: 10.1136/bmjopen-2014-006703. View

4.
McCrindle B, Rowley A, Newburger J, Burns J, Bolger A, Gewitz M . Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017; 135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484. View

5.
Maddox R, Holman R, Uehara R, Callinan L, Guest J, Schonberger L . Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015; 57(6):1116-20. PMC: 4676732. DOI: 10.1111/ped.12733. View